Paula M. Cannon

6.8k citations

79 papers · 4.4k indexed · 2 hit papers · h-index 37

Virology top 0.2%
- HIV Research and Treatment 40
Infectious Diseases top 1%
- Viral Infections and Outbreaks Research 12
Genetics top 1%
- Virus-based gene therapy research 23
Business and International Management top 2%
Immunology top 5%
- Immune Cell Function and Interaction 12
Molecular Biology
- CRISPR and Genetic Engineering 20
Epidemiology
- Cytomegalovirus and herpesvirus research 13
Public Health, Environmental and Occupational Health
- Mosquito-borne diseases and control 9
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 9

Co-authors: Susan M. Kingsman Alan J. Kingsman W. French Anderson Colin M. Exline Gaetano Romano Joanne C. Griffiths Michael C. Holmes Philip D. Gregory
Cited by: Virology Infectious Diseases Genetics
Partner nations: United States United Kingdom Spain

In The Last Decade

Paula M. Cannon

76 papers receiving 4.3k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2010 Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
1995 A transient three-plasmid expression system for the production of high titer retroviral vectors

Peers

Countries citing papers authored by Paula M. Cannon

Since Specialization

Citations

This map shows the geographic impact of Paula M. Cannon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula M. Cannon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula M. Cannon more than expected).

Fields of papers citing papers by Paula M. Cannon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paula M. Cannon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula M. Cannon. The network helps show where Paula M. Cannon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paula M. Cannon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paula M. Cannon Line = papers co-authored together Paula M. Cannon links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Overcoming barriers to commercially pre-viable gene and cell therapies for rare and ultra-rare diseases David Barrett,Paula M. Cannon,Federico Mingozzi,Matthew H. Porteus,Isabelle Rivière,Terence R. Flotte	2025	0
2	Reprogramming human B cells with custom heavy-chain antibodies Geoffrey L. Rogers,Chun Huang,Atishay Mathur,Xiaoli Huang,Hsu-Yu Chen,Kalya Stanten,Heidy Morales,Chan-Hua Chang,Eric J. Kezirian,Paula M. Cannon	2024	4
3	Comparison of SARS-CoV-2 entry inhibitors based on ACE2 receptor or engineered Spike-binding peptides George N. Llewellyn,Hsu-Yu Chen,Geoffrey L. Rogers,Xiaoli Huang,Philip Sell,Jill Henley,Paula M. Cannon	2023	4
4	SARS-CoV-2 Enters Human Leydig Cells and Affects Testosterone Production In Vitro Lu Li,Chantal M. Sottas,Hsu-Yu Chen,Yuchang Li,Haoyi Cui,Jason Villano,Joseph L. Mankowski,Paula M. Cannon,Vassilios Papadopoulos	2023	7
5	Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytes Geoffrey L. Rogers,Chun Huang,Robert D. E. Clark,Eduardo Seclén,Hsu-Yu Chen,Paula M. Cannon	2021	24
6	Cytoplasmic Tail Truncation of SARS-CoV-2 Spike Protein Enhances Titer of Pseudotyped Vectors but Masks the Effect of the D614G Mutation Hsu-Yu Chen,Chun Huang,Lü Tian,Xiaoli Huang,Chennan Zhang,George N. Llewellyn,Geoffrey L. Rogers,Kevin Andresen,Maurice R.G. O’Gorman,Ya‐Wen Chen,Paula M. Cannon	2021	20
7	Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development Paula M. Cannon,Aravind Asokan,Agnieszka Czechowicz,Paula T. Hammond,Donald B. Kohn,André Lieber,Punam Malik,Peter Marks,Matthew H. Porteus,Els Verhoeyen,Drew Weissman,Irving L. Weissman,Hans‐Peter Kiem	2021	17
8	Knockdown of Astrocytic Monocarboxylate Transporter 4 in the Motor Cortex Leads to Loss of Dendritic Spines and a Deficit in Motor Learning Adam J. Lundquist,George N. Llewellyn,Susan H. Kishi,Nicolaus A. Jakowec,Paula M. Cannon,Giselle M. Petzinger,Michael W. Jakowec	2021	13
9	Rational Selection of CRISPR-Cas9 Guide RNAs for Homology-Directed Genome Editing Kristina J. Tatiossian,Robert D. E. Clark,Chun Huang,Matthew E. Thornton,Brendan H. Grubbs,Paula M. Cannon	2020	23
10	Timothy Ray Brown: The Serendipitous Hero of HIV Cure Research Thomas J. Hope,Nichole R. Klatt,Jonah B. Sacha,Paula M. Cannon	2020	0
11	Homologous Recombination-Based Genome Editing by Clade F AAVs Is Inefficient in the Absence of a Targeted DNA Break Geoffrey L. Rogers,Hsu-Yu Chen,Heidy Morales,Paula M. Cannon	2019	13
12	Gene Therapy Approaches to Human Immunodeficiency Virus and Other Infectious Diseases Geoffrey L. Rogers,Paula M. Cannon	2017	11
13	Human Immunodeficiency Virus Immune Cell Receptors, Coreceptors, and Cofactors: Implications for Prevention and Treatment Andrew W. Woodham,Joseph G. Skeate,Adriana Sanna,Julia R. Taylor,Diane M. Da Silva,Paula M. Cannon,W. Martin Kast	2016	37
14	A Cure for HIV Infection: “Not in My Lifetime” or “Just Around the Corner”? Michael M. Lederman,Paula M. Cannon,Judith S. Currier,Carl H. June,Hans‐Peter Kiem,Daniel R. Kuritzkes,Sharon R. Lewin,David M. Margolis,Joseph M. McCune,John W. Mellors,Timothy W. Schacker,Rafick‐Pierre Sékaly,Pablo Tebas,Bruce D. Walker,Daniel C. Douek	2016	29
15	Clinical Applications of Genome Editing to HIV Cure Cathy X. Wang,Paula M. Cannon	2016	11
16	Pre-clinical Modeling of CCR5 Knockout in Human Hematopoietic Stem Cells by Zinc Finger Nucleases Using Humanized Mice Ursula Hofer,Jill Henley,Colin M. Exline,Orla Mulhern,Emilia Fernández López,Paula M. Cannon	2013	31
17	Tissue-specific restriction of cyclophilin A-independent HIV-1- and SIV-derived lentiviral vectors Christoph Kahl,Paula M. Cannon,Jill Oldenburg,A. F. Tarantal,Donald B. Kohn	2008	12
18	Receptor use by the Whitewater Arroyo virus glycoprotein Therese Reignier,Jill Oldenburg,M. FLANAGAN,Genevieve A. Hamilton,Vanessa K. Martin,Paula M. Cannon	2007	21
19	Identification of Regions in the Moloney Murine Leukemia Virus SU Protein That Tolerate the Insertion of an Integrin-Binding Peptide Bonnie Wu,Jianfeng Lü,Timothy K. Gallaher,W. French Anderson,Paula M. Cannon	2000	43
20	Mobilization of plasmid ntp16 by a variety of conjugative plasmids Paula M. Cannon,Peter Strike	1988	1

About Paula M. Cannon

Paula M. Cannon is a scholar working on Virology, Infectious Diseases and Genetics, having authored 79 papers that have together received 4.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (40 papers), Virus-based gene therapy research (23 papers), CRISPR and Genetic Engineering (20 papers), Cytomegalovirus and herpesvirus research (13 papers), Viral Infections and Outbreaks Research (12 papers), Immune Cell Function and Interaction (12 papers), Mosquito-borne diseases and control (9 papers) and Monoclonal and Polyclonal Antibodies Research (9 papers). The work is most often cited by research in Virology (1.6k citations), Infectious Diseases (1.1k citations) and Genetics (1.6k citations). Paula M. Cannon has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Susan M. Kingsman, Alan J. Kingsman, W. French Anderson, Colin M. Exline, Gaetano Romano, Joanne C. Griffiths, Michael C. Holmes, Philip D. Gregory, Jianbin Wang and Jill Oldenburg.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact